Yew Bio-Pharm Group, Inc. Earnings Per Share, Basic and Diluted
Yew Bio-Pharm Group, Inc. reported Earnings Per Share, Basic and Diluted of -$0.03 per share for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-11-15
- Yew Bio-Pharm Group, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.03, a 250.00% decline year-over-year.
- Yew Bio-Pharm Group, Inc. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.01.
- Yew Bio-Pharm Group, Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was $0.02, a 0.00% change year-over-year.
- Yew Bio-Pharm Group, Inc. earnings per share, basic and diluted for the quarter ending 2019-12-31 was -$0.04.
- Yew Bio-Pharm Group, Inc. earnings per share, basic and diluted for fiscal 2020 was $0.03, a 50.00% increase from fiscal 2019.
- Yew Bio-Pharm Group, Inc. earnings per share, basic and diluted for fiscal 2019 was $0.02.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-09-30 | -$0.03 10-Q · filed 2021-11-15 | $0.02 10-Q · filed 2021-11-15 | ||
| 2020-12-31 | -$0.01 derived: net income ÷ weighted average shares · filed 2021-03-30 | $0.01 derived: net income ÷ weighted average shares · filed 2021-11-15 | $0.03 10-K · filed 2021-03-30 | |
| 2020-09-30 | $0.02 10-Q · filed 2021-11-15 | $0.04 10-Q · filed 2021-11-15 | ||
| 2019-12-31 | -$0.04 derived: net income ÷ weighted average shares · filed 2021-03-30 | -$0.02 derived: net income ÷ weighted average shares · filed 2021-03-30 | $0.02 10-K · filed 2021-03-30 | |
| 2019-09-30 | $0.02 10-Q · filed 2020-11-13 | $0.06 10-Q · filed 2020-11-13 |